Traders’ Cafe with Zak Mir: ORPH, POLB, ABDX, KZG, CGH, CPX, LIFE & PUR via Vox Markets

Open Orphan (ORPH), the clinical research group, has become famous as much as anything else for its involvement in Human Challenge Studies.

By Zak Mir

Today the company said it notes the announcement dated 1 September 2021 from Barvarian Nordic A/S reporting positive results received from a human challenge study testing its respiratory syncytial virus vaccine candidate, MVA-BN® RSV. hVIVO, a subsidiary of Open Orphan, conducted the Phase 2 double-blinded, placebo-controlled trial using its RSV Human Challenge Study Model.

Open Orphan (ORPH) offshoot and market newcomer, Poolbeg Pharma (POLB) served up news of its own. The clinical-stage infectious disease pharmaceutical company with a capital-light clinical model provided an update on the strengthening of its intellectual property position around the lead product, POLB 001, a small molecule immunomodulator for the treatment of severe influenza. The company said it continues to evaluate POLB 001’s therapeutic uses beyond severe influenza.

Testing group Abingdon Health (ABDX) has seen its shares retreat quite markedly since the flurry through 80p in the wake of the Covid self test launch last month. The latest here is that the testing group has launched, initially for research use only, of a score-card product available alongside the AbC-19™ rapid test, which provides a semi-quantitative result to indicate the strength of antibody response and possible immunity. This is achieved by the use of a simple line intensity score-card as illustrated here which is available as an accessory to the standard Lateral Flow device for research applications.

AIM quoted investment company, Kazera Gold (KZG) said that following the conclusion of its plan to commence Tantalum production at its mine in Tantalite Valley it has now entered into an Off-Take Agreement for the sale of all Tantalum produced by it. The 3-year contract, through to 31 December 2024, has been entered into with Jiujiang Jinxin Nonferrous Metals at Tantalite Valley. A test sample assay has already been approved by the customer and airfreighted to China for factory testing. Interest has also been expressed in developing the company’s Lithium deposit.

AIM-quoted gold miner Chaarat Gold (CGH), has so far not seen the sharp recovery in some of the share prices of its peers filter through to its market cap. The company with an operating mine in Armenia, and assets at various stages of development in the Kyrgyz Republic, said that it will release its interim financial results for the six months to 30 June 2021 on September 9, the same day as a new investor presentation. It will be interesting to see whether all of this finally brings positive sentiment back to the group, given the presence and ongoing share buying of its major shareholder, and the way companies still at the discovery stage enjoy far higher ratings.

Supercapacitors group CAP- XX (CPX) announced that Spire Health, which provides respiratory remote patient monitoring, has selected the CAP-XX supercap to provide the peak power needed to deliver respiratory and pulse rate monitoring for pulmonary patients in the company’s new Health Tag garment-adhered sensor. The company’s original Health Tags used CAP-XX supercapacitors to deliver wellness alerts to consumers. The new Health Tag uses CAP-XX supercapacitors to notify a patient’s care team of changes in their health in an effort to enable early interventions and prevent hospital admissions.

It would appear the world domination concept is not just for James Bond films. The latest from CBD and hemp product supplier, Love Hemp (LIFE) is that it has signed a distribution partnership for Asia with eCargo Holdings. Love Hemp’s initial launch into the region will be both online and offline in Hong Kong and South East Asia retail channels, before expanding into India and Japan later, through strategic partnerships with eCommerce marketplaces such as Flipkart and Rakuten in 2022. The company said the partnership is a significant step forward in its global growth strategy. The global CBD market is forecast to exceed $20 billion by 2024, a 614% increase from today’s valuation, with Asia representing a sizeable part of this market.

Pure Gold Mining (PUR) delivered its August update from the company’s PureGold Mine in Red Lake, Ontario. Here it completed the installation of all six CIP interstage screens and a trommel screen on the SAG mill last month, leading to a new single day record of 1,037 tonnes of ore1 on August 31, 30% higher than the current design capacity of 800 tpd. Pure Gold said it had made significant strides in August toward its goal of consistently producing 1,000 tonnes per day of high-grade ore by the end of the year.

Read More

Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.